The influence of nutritional factors on the prognosis of multiple sclerosis

Author(s): vonGeldern G, Mowry EM

Abstract

The effect of nutrition and dietary supplements on the course of multiple sclerosis (MS) is a topic of great interest to both patients and clinicians. In particular, vitamin D status has been shown to influence both the incidence and the course of MS. High vitamin D levels are probably protective against the development of MS, although the efficacy of vitamin D supplementation in slowing progression of MS remains to be established. The influence of polyunsaturated fatty acids (PUFAs) on the development and course of MS has also long been under investigation. Small clinical trials suggest a modest reduction in the severity and duration of relapses in patients with MS receiving PUFA supplements. Other nutritional factors have been evaluated for their effect on MS disease progression, including milk proteins, gluten, probiotics, antioxidants (uric acid, vitamins A, C and E, lipoic acid), polyphenols, Ginkgo biloba extracts and curcumin. However, further studies are needed to evaluate the effects of these dietary components on the relapse rate and progression of MS. This Review gives an overview of the literature on the nutritional factors most commonly implicated as having an effect on MS and discusses the biological rationale that is thought to underlie their influence.

Similar Articles

Epidemiology and diagnosis of multiple sclerosis

Author(s): Hassan-Smith G, Douglas MR

Multiple sclerosis: current treatment algorithms

Author(s): Río J, Comabella M, Montalban X

Predictors of alternative medicine use by multiple sclerosis patients

Author(s): Marrie RA, Hadjimichael O, Vollmer T

Complementary and alternative medicine for multiple sclerosis

Author(s): Schwarz S, Knorr C, Geiger H, Flachenecker P

A randomized pilot study of naturopathic medicine in multiple sclerosis

Author(s): Shinto L, Calabrese C, Morris C, Yadav V, Griffith D, et al.

Comparative effects of DHA and EPA on cell function

Author(s): Gorjão R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M, et al.

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

Author(s): Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, et al.

Leukotrienes in the cerebrospinal fluid of multiple sclerosis patients

Author(s): Neu I, Mallinger J, Wildfeuer A, Mehlber L

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients

Author(s): Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, et al.